Showing 1 - 6 results of 6 for search 'Shui‐Lian Zhang', query time: 0.25s Refine Results
  1. 1
    Confidential communications technique based on message block precoder in multi-user MIMO systems

    Confidential communications technique based on message block precoder in multi-user MIMO systems by Yao ZHU, Yi-jun ZHU, Shui-lian ZHANG, Yong-gang LIU

    Published 2012-03-01
    Get full text
    Article
  2. 2
    Confidential communications technique based on message block precoder in multi-user MIMO systems

    Confidential communications technique based on message block precoder in multi-user MIMO systems by Yao ZHU, Yi-jun ZHU, Shui-lian ZHANG, Yong-gang LIU

    Published 2012-03-01
    Get full text
    Article
  3. 3
    Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients

    Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients by Hong‐xia Tian, Zhi‐hong Chen, Guang‐Ling Jie, Zhen Wang, Hong‐hong Yan, Si‐pei Wu, Shui‐lian Zhang, Dan‐xia Lu, Xu‐chao Zhang, Yi‐long Wu

    Published 2023-01-01
    Get full text
    Article
  4. 4
    An integrated biomarker of PD‐L1 expression and intraepithelial CD8+ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of brain metastases

    An integrated biomarker of PD‐L1 expression and intraepithelial CD8+ T cell infiltration was associated with the prognosis of lung cancer patients after intracranial resection of b... by Lin‐Lin Li, De‐Xiang Zhou, Ming Lu, Dong Zhou, Xiao‐Feng Lin, Yu Chen, Kai Yin, Hui‐Bo Feng, Wei‐Bang Guo, Zhi Xie, Wen‐Qing Yan, Zhi‐Yi Lv, Dan‐Xia Lu, Shui‐Lian Zhang, Xu‐Chao Zhang

    Published 2022-07-01
    Get full text
    Article
  5. 5
    PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma

    PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma by Yu-Min Zhong, Yu-Min Zhong, Yu-Min Zhong, Kai Yin, Kai Yin, Yu Chen, Yu Chen, Zhi Xie, Zhi Xie, Zhi-Yi Lv, Zhi-Yi Lv, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Bin-Chao Wang, Wen-Zhao Zhong, Ling-Ling Gao, Ling-Ling Gao, Wen-Bin Zhou, Ji Chen, Ji Chen, Hai-Yan Tu, Ri-Qiang Liao, Dong-Kun Zhang, Shui-Lian Zhang, Shui-Lian Zhang, Dan-Xia Lu, Dan-Xia Lu, Hong-Bo Zheng, Heng-Hui Zhang, Yi-Long Wu, Xu-Chao Zhang, Xu-Chao Zhang, Xu-Chao Zhang, Xu-Chao Zhang

    Published 2022-10-01
    Get full text
    Article
  6. 6
    Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma

    Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma‐like carcinoma by Yu‐Min Zhong, Ji Chen, Jie Jiang, Wen‐Bin Zhou, Ling‐Ling Gao, Shui‐Lian Zhang, Wen‐Qing Yan, Yu Chen, Dong‐Kun Zhang, Dan‐Xia Lu, Zhi‐Yi Lv, Zhi Xie, Ying Huang, Wei‐Bang Guo, Bin‐Chao Wang, Jin‐Ji Yang, Xue‐Ning Yang, Yi‐Long Wu, Xu‐Chao Zhang

    Published 2024-01-01
    Get full text
    Article

Search Tools: